News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Two new oral ICIs in solid tumors showcasing improved ease of use compared with antibodies – ESMO
Stefan Symeonides/cancer.ed.ac.uk
Dec 11, 2024, 10:27

Two new oral ICIs in solid tumors showcasing improved ease of use compared with antibodies – ESMO

ESMO – Eur. Oncology shared an article by Stefan Symeonides on X:

“Early-phase trials presented at ESMOAsia24 report the potential for two new oral small-molecule ICIs in Solid Tumours showcasing favourable benefit-risk profiles and improved ease of use compared w/ antibodies.”

Two new oral ICIs in solid tumors showcasing improved ease of use compared with antibodies - ESMO

Two oral immune checkpoint inhibitors show preliminary efficacy and manageable safety in early trials.

Authors: Stefan Symeonides, et al.

Two new oral ICIs in solid tumors showcasing improved ease of use compared with antibodies - ESMO

cancer ESMO - Eur. Oncology ESMOASIA24 fight against cancer Global fight against cancer OncoDaily Oncology solid tumours Stefan Symeonides
Special Coverage
Science
Feb 22, 2025, 15:33
Updated ESMO Clinical Practice Guideline on Hepatocellular Carcinoma
Science
Feb 22, 2025, 15:14
Erman Akkus: Stage specific characterization of early-onset colorectal cancer
Blog
Feb 22, 2025, 15:04
John Gordon: Successful CAR Tcell Therapy - "It's a Bug's Life"
Blog
Feb 22, 2025, 14:43
Giannis Mountzios: How active ADCs against oncogene-addicted NSCLC?
Science
Feb 22, 2025, 14:10
Yan Leyfman: Advancing CAR T-Cell Therapy - Off-the-Shelf Allogeneic Approach
Science
Feb 22, 2025, 13:28
Elvina Almuradova: Immunotherapy for HPV-Associated Cancers
Opinion
Feb 22, 2025, 13:10
Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding
Science
Feb 22, 2025, 13:10
Why immunotherapy has struggled in EGFR+ lung cancer - EGFR Positive Lung Cancer UK
Blog
Feb 22, 2025, 13:04
Debate session on the management of stage III NSCLC in the IO era - ESTRO
Celebrities
Feb 22, 2025, 11:40
Remembering Saxophonist James Casey: His Battle with Colon Cancer and Advocacy
Career
Feb 22, 2025, 11:36
Joseph H. Antin Received ASTCT Lifetime Achievement Award at 2025 Tandem Meetings
Science
Feb 22, 2025, 11:28
Myeloma Paper of the Day, February 22nd, suggested by Robert Orlowski